Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

After a serious stock market slump, the boss of this FTSE 250 biotech company has reportedly highlighted its takeover ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

PacBio shares appear undervalued ... to read my prior PacBio articles for discussions on those). Likewise, while Illumina has made noise about becoming more competitive in the long-read market ...

DNA sequencing specialist’s decision to list in London in 2021 was seen as a victory for the market at the time ...

According to a GlobalData market model, the top three NGS companies by global market share in 2024 were Illumina, Pacific Biosciences, and Thermo Fisher Scientific. Illumina holds a 34.5% market ...

"It's exciting to see, through our customers' results, how Callisto Apps are helping clinical labs with consistent and cost-efficient whole genome sequencing with Illumina and PacBio. Callisto is ...

"It's exciting to see, through our customers' results, how Callisto Apps are helping clinical labs with consistent and cost-efficient whole genome sequencing with Illumina and PacBio. Callisto is also ...

According to a GlobalData market model, the top three NGS companies by global market share in 2024 were Illumina, Pacific Biosciences, and Thermo Fisher Scientific. Illumina holds a 34.5% market share ...

Burstein covers the Healthcare sector, focusing on stocks such as Pacific Biosciences, Agilent, and Exact Sciences. Currently, the analyst consensus on Illumina is a Hold with an average price ...